<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema" xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema" xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dct="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/" xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/" xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/" xmlns:cja="http://www.elsevier.com/xml/cja/schema" xmlns:ja="http://www.elsevier.com/xml/ja/schema" xmlns:bk="http://www.elsevier.com/xml/bk/schema" xmlns:ce="http://www.elsevier.com/xml/common/schema" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:cals="http://www.elsevier.com/xml/common/cals/schema" xmlns:tb="http://www.elsevier.com/xml/common/table/schema" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema" xmlns:xlink="http://www.w3.org/1999/xlink"><rdf:RDF><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.dib.2021.107747"><dct:format>application/xml</dct:format><dct:title>Data on plasma tumour and metabolism related proteins&#x2019; potential in differentiation of HFpEF-PH from PAH and in prognosis of left heart failure patients with pulmonary hypertension</dct:title><dct:creator>Salaheldin Ahmed</dct:creator><dct:creator>Abdulla Ahmed</dct:creator><dct:creator>G&#246;ran R&#229;degran</dct:creator><dct:subject><rdf:Bag><rdf:li>Prognosis</rdf:li><rdf:li>HFpEF</rdf:li><rdf:li>Pulmonary hypertension</rdf:li><rdf:li>Pulmonary hypertension due to left heart disease</rdf:li><rdf:li>PAH</rdf:li><rdf:li>Haemodynamics</rdf:li><rdf:li>Proteomics</rdf:li><rdf:li>Cancer</rdf:li></rdf:Bag></dct:subject><dct:description>Data in Brief 40 (2022). doi:10.1016/j.dib.2021.107747</dct:description><prism:aggregationType>journal</prism:aggregationType><prism:publicationName>Data in Brief</prism:publicationName><prism:copyright>&#169; 2021 Published by Elsevier Inc.</prism:copyright><dct:publisher>Elsevier Inc.</dct:publisher><prism:issn>2352-3409</prism:issn><prism:volume>40</prism:volume><prism:coverDisplayDate>February 2022</prism:coverDisplayDate><prism:doi>10.1016/j.dib.2021.107747</prism:doi><prism:url>http://dx.doi.org/10.1016/j.dib.2021.107747</prism:url><dct:identifier>doi:10.1016/j.dib.2021.107747</dct:identifier><bam:articleNumber>107747</bam:articleNumber><oa:openAccessInformation><oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus><oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-12-21T19:04:50Z</oa:openAccessEffective><oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#ElsevierWaived</oa:sponsorType></oa:sponsor><oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by/4.0/</oa:userLicense></oa:openAccessInformation><cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY license.</cp:licenseLine></rdf:Description></rdf:RDF><dp:document-properties><dp:aggregation-type>Journals</dp:aggregation-type><dp:version-number>S300.2</dp:version-number></dp:document-properties><ja:article docsubtype="dat" version="5.6" xml:lang="en"><ja:item-info><ja:jid>DIB</ja:jid><ja:aid>107747</ja:aid><ce:article-number>107747</ce:article-number><ce:pii>S2352-3409(21)01022-2</ce:pii><ce:doi>10.1016/j.dib.2021.107747</ce:doi><ce:document-thread><ce:refers-to-document id="ref0001"><ce:pii>S0167-5273(21)01690-9</ce:pii><ce:doi>10.1016/j.ijcard.2021.10.136</ce:doi></ce:refers-to-document></ce:document-thread><ce:copyright type="unknown" year="2021"/></ja:item-info><ja:head><ce:dochead id="dchd0001"><ce:textfn id="dhtxt0001">Data Article</ce:textfn></ce:dochead><ce:title id="tte0002">Data on plasma tumour and metabolism related proteins&#x2019; potential in differentiation of HFpEF-PH from PAH and in prognosis of left heart failure patients with pulmonary hypertension</ce:title><ce:author-group id="aut0001"><ce:author id="au0001" author-id="S2352340921010222-65b2d238c234e49a6badd81962ff0206" orcid="0000-0001-7086-6262"><ce:given-name>Salaheldin</ce:given-name><ce:surname>Ahmed</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/software">Software</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/validation">Validation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing &#x2013; original draft</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/visualization">Visualization</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0002" author-id="S2352340921010222-31d5749ddc47f13a0ccb16d7a92e45fa"><ce:given-name>Abdulla</ce:given-name><ce:surname>Ahmed</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/visualization">Visualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0003" author-id="S2352340921010222-cb2cb0b47f170819321aae02c36a87d7"><ce:given-name>G&#246;ran</ce:given-name><ce:surname>R&#229;degran</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/resources">Resources</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/supervision">Supervision</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/project-administration">Project administration</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/funding-acquisition">Funding acquisition</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address type="email" xlink:href="mailto:goranradegran@hotmail.com" id="ead0001">goranradegran@hotmail.com</ce:e-address></ce:author><ce:affiliation id="aff0001" affiliation-id="S2352340921010222-e3ec817fdefe8026773a4dae35e1dc04"><ce:label>a</ce:label><ce:textfn id="cetextfn0001">Department of Clinical Sciences Lund, Cardiology, Lund University, Lund, Sweden</ce:textfn><sa:affiliation><sa:organization>Department of Clinical Sciences Lund, Cardiology</sa:organization><sa:organization>Lund University</sa:organization><sa:city>Lund</sa:city><sa:country>Sweden</sa:country></sa:affiliation><ce:source-text id="staff0001">aDepartment of Clinical Sciences Lund, Cardiology, Lund University, Lund, Sweden</ce:source-text></ce:affiliation><ce:affiliation id="aff0002" affiliation-id="S2352340921010222-5cd4773d6c2dcf06827b0c85c98680a7"><ce:label>b</ce:label><ce:textfn id="cetextfn0002">The Haemodynamic Lab, The Section for Heart Failure and Valvular Disease, Heart and Lung Medicine, Sk&#229;ne University Hospital, Lund, Sweden</ce:textfn><sa:affiliation><sa:organization>The Haemodynamic Lab, The section for Heart Failure and Valvular Disease, Heart and Lung Medicine</sa:organization><sa:organization>Sk&#229;ne University Hospital</sa:organization><sa:city>Lund</sa:city><sa:country>Sweden</sa:country></sa:affiliation><ce:source-text id="staff0002">bThe Haemodynamic Lab, The section for Heart Failure and Valvular Disease, Heart and Lung Medicine, Sk&#229;ne University Hospital, Lund, Sweden</ce:source-text></ce:affiliation><ce:correspondence id="cor0001"><ce:label>&#x204e;</ce:label><ce:text>Corresponding author at: Department of Cardiology, Sk&#229;ne University Hospital, 221 85 Lund, Sweden.</ce:text><sa:affiliation><sa:organization>Department of Cardiology, Sk&#229;ne University Hospital</sa:organization><sa:city>Lund</sa:city><sa:country>Sweden</sa:country></sa:affiliation></ce:correspondence></ce:author-group><ce:date-received day="24" month="11" year="2021"/><ce:date-revised day="16" month="12" year="2021"/><ce:date-accepted day="20" month="12" year="2021"/><ce:abstract id="abs0001" view="all" class="author"><ce:section-title id="cesectitle0001">Abstract</ce:section-title><ce:abstract-sec id="abss0001" view="all"><ce:simple-para id="spara007" view="all">The data in the current paper constitutes supplementary material to our article entitled &#x201c;Plasma tumour and metabolism related biomarkers AMBP, LPL and Glyoxalase I differentiate heart failure with preserved ejection fraction with pulmonary hypertension from pulmonary arterial hypertension&#x201d; Ahmed et&#160;al. (2021). The study investigated 69 plasma tumour- and metabolism related proteins in healthy controls (<ce:italic>n</ce:italic>&#160;=&#160;20) and in 115 patients of whom 48 had pulmonary arterial hypertension (PAH; <ce:italic>n</ce:italic>&#160;=&#160;48) and 67 with left heart failure with pulmonary hypertension (LHF-PH) [heart failure with- preserved ejection fraction-PH (HFpEF-PH; <ce:italic>n</ce:italic>&#160;=&#160;31) and reduced ejection fraction-PH (HFrEF-PH; <ce:italic>n</ce:italic>&#160;=&#160;36)]. The haemodynamic data were obtained with right heart catheterization, and clinical data from medical records. The present article describe the plasma levels of tumour- and metabolism related proteins, analyzed with proximity extension assay, along with their uni- and multivariable diagnostic and prognostic potential. High sRAGE levels univariably emerged as a negative prognostic marker in LHF-PH.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id="keys0001" view="all" class="keyword"><ce:section-title id="cesectitle0002">Keywords</ce:section-title><ce:keyword id="key0001"><ce:text id="cetext0002">Prognosis</ce:text></ce:keyword><ce:keyword id="key0002"><ce:text id="cetext0003">HFpEF</ce:text></ce:keyword><ce:keyword id="key0003"><ce:text id="cetext0004">Pulmonary hypertension</ce:text></ce:keyword><ce:keyword id="key0004"><ce:text id="cetext0005">Pulmonary hypertension due to left heart disease</ce:text></ce:keyword><ce:keyword id="key0005"><ce:text id="cetext0006">PAH</ce:text></ce:keyword><ce:keyword id="key0006"><ce:text id="cetext0007">Haemodynamics</ce:text></ce:keyword><ce:keyword id="key0007"><ce:text id="cetext0008">Proteomics</ce:text></ce:keyword><ce:keyword id="key0008"><ce:text id="cetext0009">Cancer</ce:text></ce:keyword></ce:keywords></ja:head></ja:article></doc:document>
